We are live on
!
Find out more
Apogee Therapeutics
APGE
APGE
139 hedge funds and large institutions have $3.29B invested in Apogee Therapeutics in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
55% more capital invested
Capital invested by funds: $2.13B → $3.29B (+$1.16B)
4.24% more ownership
Funds ownership: 120.42% → 124.65% (+4.2%)
4% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 46
0% more funds holding
Funds holding: 139 → 139 (0)
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
83% less call options, than puts
Call options by funds: $2.65M | Put options by funds: $15.2M
Holders
139
Holders Change
–
Holders Change %
0%
% of All Funds
2%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.1%
New
25
Increased
48
Reduced
46
Closed
25
Calls
$2.65M
Puts
$15.2M
Net Calls
-$12.6M
Net Calls Change
-$12M
Top Buyers
Top Sellers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$35.9M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$16M |
| 3 |
DM
Deerfield Management
New York
|
-$12.9M |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
-$12.5M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$9.84M |
